Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “E Coli Infections”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT05652556
What this trial is testing

Quinolone Resistance Profiles and Mechanisms of Staphylococcus Aureus and Escherichia Coli From Humans, Chicken and Catfish Farms in Indonesia

Who this might be right for
Drug Resistance, Microbial
Erasmus Medical Center 480
Testing effectiveness (Phase 2)UnknownNCT02537847
What this trial is testing

Sitafloxacin and Ertapenem Treatment for Acute Pyelonephritis Caused by Escherichia Coli

Who this might be right for
Infection Due to Escherichia ColiAcute Pyelonephritis
Mahidol University 96
Large-scale testing (Phase 3)Study completedNCT02142751
What this trial is testing

Fosfomycin Versus Meropenem or Ceftriaxone in Bacteriemic Infections Caused by Multidrug Resistance in E.Coli

Who this might be right for
Infection Due to ESBL Escherichia Coli
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla 161
Not applicableStudy completedNCT00167999
What this trial is testing

Study Evaluating Piperacillin-Tazobactam on Certain Bacteria in Hematology and Oncology Units

Who this might be right for
Gram-Positive Bacterial InfectionsEscherichia Coli InfectionsKlebsiella Infections
Wyeth is now a wholly owned subsidiary of Pfizer 200
Large-scale testing (Phase 3)Active Not RecruitingNCT05662020
What this trial is testing

Evaluate the Immunogenicity and Safety of HPV Vaccine in Healthy Female Participants Aged 9-26 Years in China

Who this might be right for
Human Papillomavirus Infection
Beijing Health Guard Biotechnology, Inc 2,750
Large-scale testing (Phase 3)UnknownNCT05668572
What this trial is testing

A Phase III Trial Evaluates the Efficacy, Immunogenicity and Safety Profile of HPV Vaccine

Who this might be right for
Human Papillomavirus Infection
Beijing Health Guard Biotechnology, Inc 12,000
Large-scale testing (Phase 3)Active Not RecruitingNCT05056402
What this trial is testing

An Immuno-bridging Study of a Nonavalent HPV Vaccine (E.Coli) in Healthy Population Aged 9-17 vs Aged 18-26 Years Old

Who this might be right for
Cervical CancerCondylomata Acuminata
Xiamen University 1,382
Not applicableStudy completedNCT03303937
What this trial is testing

Characteristics of Lower Respiratory Tract Escherichia Coli Isolates in Mechanically Ventilated Intensive Care Patients

Who this might be right for
Nosocomial PneumoniaVentilator Associated PneumoniaEscherichia Coli Infections+3 more
Hôpital Louis Mourier 289
Not applicableStudy completedNCT04764500
What this trial is testing

Developing Microbials to Fight Extended-spectrum Beta-lactamase (ESBL)-Producing Escherichia Coli

Who this might be right for
Extended Spectrum Beta Lactamases (ESBL) E. Coli
University Hospital, Basel, Switzerland 39
Not applicableStudy completedNCT00363220
What this trial is testing

Community - Associated Extended-spectrum Beta-lactamases (ESBL)

Who this might be right for
InfectionE Coli InfectionsKlebsiella Infections+1 more
University of Pittsburgh 100
Early research (Phase 1)Study completedNCT04634513
What this trial is testing

Shigella CVD 31000: Study of Responses With Shigella-ETEC Vaccine Strain CVD 1208S-122

Who this might be right for
Shigella InfectionEnterotoxigenic Escherichia Coli Infection
University of Maryland, Baltimore 53
Not applicableStudy completedNCT03206255
What this trial is testing

Immuno-persistence Study of a Recombinant Human Papillomavirus 16/18 Bivalent Vaccine in Preadolescent Girls

Who this might be right for
Cervical Intraepithelial NeoplasiaCervical CancerVaginal Intraepithelial Neoplasia+2 more
Jun Zhang 940
Not applicableStudy completedNCT00915213
What this trial is testing

Incidence of Antibiotic Resistant E.Coli in Patients Undergoing Repeat Prostate Biopsy

Who this might be right for
Bacterial Infection
University of California, Irvine 136
Not applicableStudy completedNCT04146922
What this trial is testing

Switch to Oral Antibiotics in Gram-negative Bacteremia

Who this might be right for
Escherichia Coli BacteremiaKlebsiella BacteraemiaEnterobacter Bacteraemia+3 more
Hamad Medical Corporation 176
Not applicableLooking for participantsNCT06080698
What this trial is testing

Gram-Negative Bloodstream Infection Oral Antibiotic Therapy Trial

Who this might be right for
Gram-negative Bacteremia
Johns Hopkins University 1,030
Early research (Phase 1)Study completedNCT03922061
What this trial is testing

Evaluation of Safety, Reactogenicity and Immunogenicity of Fractional-dose Inactivated Polio Vaccine (fIPV) Given Intradermally With Double Mutant Enterotoxigenic Escherichia Coli Heat Labile Toxin (dmLT) Adjuvant

Who this might be right for
Polio
University of Vermont 29
Not applicableStudy completedNCT03301103
What this trial is testing

PTM202 and Modulation of Host Resistance to Diarrheagenic E. Coli

Who this might be right for
Traveler's Diarrhea
NIZO Food Research 72
Not applicableUnknownNCT04969445
What this trial is testing

The Durability of Protection Study of a Recombinant HPV 16/18 Bivalent Vaccine in Female

Who this might be right for
Cervical Intraepithelial NeoplasiaCervical CancerVaginal Intraepithelial Neoplasia+2 more
Jun Zhang 647
Not applicableLooking for participantsNCT05153824
What this trial is testing

Study of the Ecological and Evolutionary Dynamics of Escherichia Coli in the Digestive Commensal Flora

Who this might be right for
Escherichia Coli; Infection, Intestinal
Assistance Publique - Hôpitaux de Paris 200
Early research (Phase 1)Study completedNCT00057525
What this trial is testing

A New Anthrax Vaccine Administered by the Intramuscular (IM) Route in Healthy Adults

Who this might be right for
Anthrax
DynPort Vaccine Company LLC, A GDIT Company 70
Next Page